| Sertraline is an antidepressant widely prescribed for major depressive disorders. In this contribution we
report a novel, rapid and sensitive spectrofluorimetric technique, developed and validated for the determination of sertraline in pharmaceutical, human urine and human plasma samples, based on the
fluorescence enhancement of the sertraline by 1, 10-phenanthroline-terbium probe with Ag nanoparticles (AgNPs). The effect of pH, buffer concentration, the order of addition of reagents, terbium and 1,
10-phenanthroline concentrations, and concentration of Ag nanoparticles (AgNPs) as well as reaction
time on the fluorescence intensity were investigated and the optimum conditions were determined. The
linear range for determination of sertraline was obtained as 0.001–3 mg L1
. The limit of detection
(bþ3s) and the limit of quantification was calculated as 2.9 104 mg L1 and 9.8 104 mg L1
, respectively. The interference effects of common excipients found in pharmaceutical preparations were
studied. The presented technique was used to determine the sertraline in pharmaceutical samples, human urine and plasma as real samples. The presented method was indicated a comparable results with
the standard analytical techniques for sertraline. Good linearity, reproducibility, recovery and limit of
detection have made this method suitable for determination of sertraline in various types of samples |